Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 91816142 | 9181614 | 2 | F | 20160830 | 20130322 | 20160906 | EXP | US-JNJFOC-20130308866 | JANSSEN | TILEY S, RAAB RE, BELLIN LS, WONG JH, UNGER J, WALKER PR. RESULTS OF THE EAST CAROLINA BREAST CENTER PHASE II TRIAL OF NEOADJUVANT METRONOMIC CHEMOTHERAPY IN TRIPLE-NEGATIVE BREAST CANCER (NCT00542191). JOURNAL OF CLINICAL ONCOLOGY 2012;30 (15) . HILDEBRAND JR, RAAB RE, MUZAFFAR M, WALKER PR. NEOADJUVANT METRONOMIC CHEMOTHERAPY IN TRIPLE-NEGATIVE BREAST CANCER (TNBC) (NCT00542191): UPDATED RESULTS FROM A PHASE II TRIAL. JOURNAL OF CLINICAL ONCOLOGY 2016;34. | 0.00 | F | Y | 0.00000 | 20160906 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 91816142 | 9181614 | 1 | PS | DOXORUBICIN | DOXORUBICIN | 1 | Intravenous (not otherwise specified) | U | U | 50718 | 24 | MG/M**2 | LIPOSOME INJECTION | /wk | |||||
| 91816142 | 9181614 | 2 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Oral | U | 0 | 60 | MG/M**2 | UNSPECIFIED | |||||||
| 91816142 | 9181614 | 3 | SS | PACLITAXEL. | PACLITAXEL | 1 | Unknown | WEEKLY | U | 0 | 80 | MG/M**2 | UNSPECIFIED | ||||||
| 91816142 | 9181614 | 4 | SS | CARBOPLATIN. | CARBOPLATIN | 1 | Unknown | U | 0 | UNSPECIFIED | |||||||||
| 91816142 | 9181614 | 5 | SS | RADIOTHERAPY | RADIATION THERAPY | 1 | Unknown | U | 0 | UNSPECIFIED | |||||||||
| 91816142 | 9181614 | 6 | C | GRANULOCYTE COLONY STIMULATING FACTOR | GRANULOCYTE COLONY-STIMULATING FACTOR NOS | 1 | Unknown | 0 | UNSPECIFIED |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 91816142 | 9181614 | 1 | Breast cancer |
| 91816142 | 9181614 | 2 | Breast cancer |
| 91816142 | 9181614 | 3 | Breast cancer |
| 91816142 | 9181614 | 4 | Breast cancer |
| 91816142 | 9181614 | 5 | Breast cancer |
| 91816142 | 9181614 | 6 | Neutrophil count decreased |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 91816142 | 9181614 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 91816142 | 9181614 | Neuropathy peripheral |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |